Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06096532 · ClinicalTrials.gov registry record · NA

Adipose Tissue Blood Flow in Aging Humans

A NA study of Healthy and Aging, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06096532 is a NA study of Healthy and Aging that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06096532, a NA study of Healthy and Aging, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The goal of this basic science clinical trial is to understand whether adipose tissue blood flow changes between younger and older healthy adults. The main question\[s\] it aims to answer are: * Is basal and nutrient responsive adipose tissue blood flow (ATBF) different between younger and older adults * What molecular and systemic signatures related to adipose tissue blood flow are altered between these two groups. Participants will undergo measurements of adipose tissue blood flow using the xenon washout technique, undergo 2 abdominal subcutaneous adipose tissue biopsies, and drink a sugary drink.

Conditions Studied

Interventions

  • OTHER 75 gm oral glucose load

Study Locations (1)

Minnesota

  • Mayo Clinic Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-01-15
Est. Completion 2028-12-30
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06096532

The ClinicalTrials.gov registry entry for NCT06096532 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which 75 gm oral glucose load is the first listed.

NCT06096532 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06096532 about?

NCT06096532 is a clinical study titled "Adipose Tissue Blood Flow in Aging Humans". The goal of this basic science clinical trial is to understand whether adipose tissue blood flow changes between younger and older healthy adults. The main question\[s\] it aims to answer are: * Is basal and nutrient responsive adipose tissue blood flow (ATBF) different between younger and older a...

What is the current status of trial NCT06096532?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-01-15. Estimated completion is 2028-12-30.

What conditions does trial NCT06096532 study?

This clinical trial studies the following conditions: Healthy, Aging.

What interventions are being tested in trial NCT06096532?

The interventions under investigation include: 75 gm oral glucose load (OTHER).

Who is sponsoring clinical trial NCT06096532?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06096532 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.